Global Diabetic Retinopathy (DR) Artificial Intelligence Screening System Market Growth (Status and Outlook) 2024-2030

Publication ID:

LPI06240841

Publication Date:

June 12, 2024

Pages:

119

Publisher:

LPI

Countries:

Global [1]

USD 3,660.00

IT Services [2]

Software [3]

Computing & Electronics [4]

Description:

Diabetic retinopathy (DR) represents a major cause of visual impairment in developed countries. The ever-growing incidence of DR and its complications necessitates new strategies to screen patients, prevent complications and optimize management. For this reason, DR is a major target of AI-based models, especially those that can be used for large-scale screening. AI models should recognize DR-related alterations, such as haemorrhages, exudates, cotton wool spots and neovascularization; and, starting from fundus images, establish the presence or absence of DR, and grade it according to the conventional DR grading scales.
The global Diabetic Retinopathy (DR) Artificial Intelligence Screening System market size is projected to grow from US$ 166 million in 2024 to US$ 7331 million in 2030; it is expected to grow at a CAGR of 88.0% from 2024 to 2030.
The 鈥淒iabetic Retinopathy (DR) Artificial Intelligence Screening System Industry Forecast鈥� looks at past sales and reviews total world Diabetic Retinopathy (DR) Artificial Intelligence Screening System sales in 2022, providing a comprehensive analysis by region and market sector of projected Diabetic Retinopathy (DR) Artificial Intelligence Screening System sales for 2023 through 2029. With Diabetic Retinopathy (DR) Artificial Intelligence Screening System sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Diabetic Retinopathy (DR) Artificial Intelligence Screening System industry.
This Insight Report provides a comprehensive analysis of the global Diabetic Retinopathy (DR) Artificial Intelligence Screening System landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Diabetic Retinopathy (DR) Artificial Intelligence Screening System portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms鈥� unique position in an accelerating global Diabetic Retinopathy (DR) Artificial Intelligence Screening System market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Diabetic Retinopathy (DR) Artificial Intelligence Screening System and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Diabetic Retinopathy (DR) Artificial Intelligence Screening System.
Diabetes continues to rise throughout the United States and worldwide. Estimates show that the prevalence of diabetes mellitus will rise to 578 million people (10.2%) by the year 2030 and 700 million people (10.9%) by the year 2045. This increase in the prevalence of diabetes can also lead to a corresponding increase in diabetic complications, including nephropathy, cardiovascular disease, neuropathy, and retinopathy.
This report presents a comprehensive overview, market shares, and growth opportunities of Diabetic Retinopathy (DR) Artificial Intelligence Screening System market by product type, application, key players and key regions and countries.
Segmentation by Type:
Hardware
Software
Segmentation by Application:
Medical Institutions
Great Health Scene
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
Segmentation by Type:
Hardware
Software
Segmentation by Application:
Medical Institutions
Great Health Scene
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Airdoc Technology
Digital Diagnostics
Eyenuk
RetinaLyze System
Optomed
Sibionics Technology
Aeye Health
VUNO
Medimaging Integrated Solution
EyRIS (SELENA+)
Vistel
RETINA-AI Health
Acer Medical

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Diabetic Retinopathy (DR) Artificial Intelligence Screening System Market Size 2019-2030
2.1.2 Diabetic Retinopathy (DR) Artificial Intelligence Screening System Market Size CAGR by Region (2019 VS 2023 VS 2030)
2.1.3 World Current & Future Analysis for Diabetic Retinopathy (DR) Artificial Intelligence Screening System by Country/Region, 2019, 2023 & 2030
2.2 Diabetic Retinopathy (DR) Artificial Intelligence Screening System Segment by Type
2.2.1 Hardware
2.2.2 Software
2.3 Diabetic Retinopathy (DR) Artificial Intelligence Screening System Market Size by Type
2.3.1 Diabetic Retinopathy (DR) Artificial Intelligence Screening System Market Size CAGR by Type (2019 VS 2023 VS 2030)
2.3.2 Global Diabetic Retinopathy (DR) Artificial Intelligence Screening System Market Size Market Share by Type (2019-2024)
2.4 Diabetic Retinopathy (DR) Artificial Intelligence Screening System Segment by Application
2.4.1 Medical Institutions
2.4.2 Great Health Scene
2.5 Diabetic Retinopathy (DR) Artificial Intelligence Screening System Market Size by Application
2.5.1 Diabetic Retinopathy (DR) Artificial Intelligence Screening System Market Size CAGR by Application (2019 VS 2023 VS 2030)
2.5.2 Global Diabetic Retinopathy (DR) Artificial Intelligence Screening System Market Size Market Share by Application (2019-2024)
3 Diabetic Retinopathy (DR) Artificial Intelligence Screening System Market Size by Player
3.1 Diabetic Retinopathy (DR) Artificial Intelligence Screening System Market Size Market Share by Player
3.1.1 Global Diabetic Retinopathy (DR) Artificial Intelligence Screening System Revenue by Player (2019-2024)
3.1.2 Global Diabetic Retinopathy (DR) Artificial Intelligence Screening System Revenue Market Share by Player (2019-2024)
3.2 Global Diabetic Retinopathy (DR) Artificial Intelligence Screening System Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Diabetic Retinopathy (DR) Artificial Intelligence Screening System by Region
4.1 Diabetic Retinopathy (DR) Artificial Intelligence Screening System Market Size by Region (2019-2024)
4.2 Global Diabetic Retinopathy (DR) Artificial Intelligence Screening System Annual Revenue by Country/Region (2019-2024)
4.3 Americas Diabetic Retinopathy (DR) Artificial Intelligence Screening System Market Size Growth (2019-2024)
4.4 APAC Diabetic Retinopathy (DR) Artificial Intelligence Screening System Market Size Growth (2019-2024)
4.5 Europe Diabetic Retinopathy (DR) Artificial Intelligence Screening System Market Size Growth (2019-2024)
4.6 Middle East & Africa Diabetic Retinopathy (DR) Artificial Intelligence Screening System Market Size Growth (2019-2024)
5 Americas
5.1 Americas Diabetic Retinopathy (DR) Artificial Intelligence Screening System Market Size by Country (2019-2024)
5.2 Americas Diabetic Retinopathy (DR) Artificial Intelligence Screening System Market Size by Type (2019-2024)
5.3 Americas Diabetic Retinopathy (DR) Artificial Intelligence Screening System Market Size by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Diabetic Retinopathy (DR) Artificial Intelligence Screening System Market Size by Region (2019-2024)
6.2 APAC Diabetic Retinopathy (DR) Artificial Intelligence Screening System Market Size by Type (2019-2024)
6.3 APAC Diabetic Retinopathy (DR) Artificial Intelligence Screening System Market Size by Application (2019-2024)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Diabetic Retinopathy (DR) Artificial Intelligence Screening System Market Size by Country (2019-2024)
7.2 Europe Diabetic Retinopathy (DR) Artificial Intelligence Screening System Market Size by Type (2019-2024)
7.3 Europe Diabetic Retinopathy (DR) Artificial Intelligence Screening System Market Size by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Diabetic Retinopathy (DR) Artificial Intelligence Screening System by Region (2019-2024)
8.2 Middle East & Africa Diabetic Retinopathy (DR) Artificial Intelligence Screening System Market Size by Type (2019-2024)
8.3 Middle East & Africa Diabetic Retinopathy (DR) Artificial Intelligence Screening System Market Size by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global Diabetic Retinopathy (DR) Artificial Intelligence Screening System Market Forecast
10.1 Global Diabetic Retinopathy (DR) Artificial Intelligence Screening System Forecast by Region (2025-2030)
10.1.1 Global Diabetic Retinopathy (DR) Artificial Intelligence Screening System Forecast by Region (2025-2030)
10.1.2 Americas Diabetic Retinopathy (DR) Artificial Intelligence Screening System Forecast
10.1.3 APAC Diabetic Retinopathy (DR) Artificial Intelligence Screening System Forecast
10.1.4 Europe Diabetic Retinopathy (DR) Artificial Intelligence Screening System Forecast
10.1.5 Middle East & Africa Diabetic Retinopathy (DR) Artificial Intelligence Screening System Forecast
10.2 Americas Diabetic Retinopathy (DR) Artificial Intelligence Screening System Forecast by Country (2025-2030)
10.2.1 United States Market Diabetic Retinopathy (DR) Artificial Intelligence Screening System Forecast
10.2.2 Canada Market Diabetic Retinopathy (DR) Artificial Intelligence Screening System Forecast
10.2.3 Mexico Market Diabetic Retinopathy (DR) Artificial Intelligence Screening System Forecast
10.2.4 Brazil Market Diabetic Retinopathy (DR) Artificial Intelligence Screening System Forecast
10.3 APAC Diabetic Retinopathy (DR) Artificial Intelligence Screening System Forecast by Region (2025-2030)
10.3.1 China Diabetic Retinopathy (DR) Artificial Intelligence Screening System Market Forecast
10.3.2 Japan Market Diabetic Retinopathy (DR) Artificial Intelligence Screening System Forecast
10.3.3 Korea Market Diabetic Retinopathy (DR) Artificial Intelligence Screening System Forecast
10.3.4 Southeast Asia Market Diabetic Retinopathy (DR) Artificial Intelligence Screening System Forecast
10.3.5 India Market Diabetic Retinopathy (DR) Artificial Intelligence Screening System Forecast
10.3.6 Australia Market Diabetic Retinopathy (DR) Artificial Intelligence Screening System Forecast
10.4 Europe Diabetic Retinopathy (DR) Artificial Intelligence Screening System Forecast by Country (2025-2030)
10.4.1 Germany Market Diabetic Retinopathy (DR) Artificial Intelligence Screening System Forecast
10.4.2 France Market Diabetic Retinopathy (DR) Artificial Intelligence Screening System Forecast
10.4.3 UK Market Diabetic Retinopathy (DR) Artificial Intelligence Screening System Forecast
10.4.4 Italy Market Diabetic Retinopathy (DR) Artificial Intelligence Screening System Forecast
10.4.5 Russia Market Diabetic Retinopathy (DR) Artificial Intelligence Screening System Forecast
10.5 Middle East & Africa Diabetic Retinopathy (DR) Artificial Intelligence Screening System Forecast by Region (2025-2030)
10.5.1 Egypt Market Diabetic Retinopathy (DR) Artificial Intelligence Screening System Forecast
10.5.2 South Africa Market Diabetic Retinopathy (DR) Artificial Intelligence Screening System Forecast
10.5.3 Israel Market Diabetic Retinopathy (DR) Artificial Intelligence Screening System Forecast
10.5.4 Turkey Market Diabetic Retinopathy (DR) Artificial Intelligence Screening System Forecast
10.6 Global Diabetic Retinopathy (DR) Artificial Intelligence Screening System Forecast by Type (2025-2030)
10.7 Global Diabetic Retinopathy (DR) Artificial Intelligence Screening System Forecast by Application (2025-2030)
10.7.1 GCC Countries Market Diabetic Retinopathy (DR) Artificial Intelligence Screening System Forecast
11 Key Players Analysis
11.1 Airdoc Technology
11.1.1 Airdoc Technology Company Information
11.1.2 Airdoc Technology Diabetic Retinopathy (DR) Artificial Intelligence Screening System Product Offered
11.1.3 Airdoc Technology Diabetic Retinopathy (DR) Artificial Intelligence Screening System Revenue, Gross Margin and Market Share (2019-2024)
11.1.4 Airdoc Technology Main Business Overview
11.1.5 Airdoc Technology Latest Developments
11.2 Digital Diagnostics
11.2.1 Digital Diagnostics Company Information
11.2.2 Digital Diagnostics Diabetic Retinopathy (DR) Artificial Intelligence Screening System Product Offered
11.2.3 Digital Diagnostics Diabetic Retinopathy (DR) Artificial Intelligence Screening System Revenue, Gross Margin and Market Share (2019-2024)
11.2.4 Digital Diagnostics Main Business Overview
11.2.5 Digital Diagnostics Latest Developments
11.3 Eyenuk
11.3.1 Eyenuk Company Information
11.3.2 Eyenuk Diabetic Retinopathy (DR) Artificial Intelligence Screening System Product Offered
11.3.3 Eyenuk Diabetic Retinopathy (DR) Artificial Intelligence Screening System Revenue, Gross Margin and Market Share (2019-2024)
11.3.4 Eyenuk Main Business Overview
11.3.5 Eyenuk Latest Developments
11.4 RetinaLyze System
11.4.1 RetinaLyze System Company Information
11.4.2 RetinaLyze System Diabetic Retinopathy (DR) Artificial Intelligence Screening System Product Offered
11.4.3 RetinaLyze System Diabetic Retinopathy (DR) Artificial Intelligence Screening System Revenue, Gross Margin and Market Share (2019-2024)
11.4.4 RetinaLyze System Main Business Overview
11.4.5 RetinaLyze System Latest Developments
11.5 Optomed
11.5.1 Optomed Company Information
11.5.2 Optomed Diabetic Retinopathy (DR) Artificial Intelligence Screening System Product Offered
11.5.3 Optomed Diabetic Retinopathy (DR) Artificial Intelligence Screening System Revenue, Gross Margin and Market Share (2019-2024)
11.5.4 Optomed Main Business Overview
11.5.5 Optomed Latest Developments
11.6 Sibionics Technology
11.6.1 Sibionics Technology Company Information
11.6.2 Sibionics Technology Diabetic Retinopathy (DR) Artificial Intelligence Screening System Product Offered
11.6.3 Sibionics Technology Diabetic Retinopathy (DR) Artificial Intelligence Screening System Revenue, Gross Margin and Market Share (2019-2024)
11.6.4 Sibionics Technology Main Business Overview
11.6.5 Sibionics Technology Latest Developments
11.7 Aeye Health
11.7.1 Aeye Health Company Information
11.7.2 Aeye Health Diabetic Retinopathy (DR) Artificial Intelligence Screening System Product Offered
11.7.3 Aeye Health Diabetic Retinopathy (DR) Artificial Intelligence Screening System Revenue, Gross Margin and Market Share (2019-2024)
11.7.4 Aeye Health Main Business Overview
11.7.5 Aeye Health Latest Developments
11.8 VUNO
11.8.1 VUNO Company Information
11.8.2 VUNO Diabetic Retinopathy (DR) Artificial Intelligence Screening System Product Offered
11.8.3 VUNO Diabetic Retinopathy (DR) Artificial Intelligence Screening System Revenue, Gross Margin and Market Share (2019-2024)
11.8.4 VUNO Main Business Overview
11.8.5 VUNO Latest Developments
11.9 Medimaging Integrated Solution
11.9.1 Medimaging Integrated Solution Company Information
11.9.2 Medimaging Integrated Solution Diabetic Retinopathy (DR) Artificial Intelligence Screening System Product Offered
11.9.3 Medimaging Integrated Solution Diabetic Retinopathy (DR) Artificial Intelligence Screening System Revenue, Gross Margin and Market Share (2019-2024)
11.9.4 Medimaging Integrated Solution Main Business Overview
11.9.5 Medimaging Integrated Solution Latest Developments
11.10 EyRIS (SELENA+)
11.10.1 EyRIS (SELENA+) Company Information
11.10.2 EyRIS (SELENA+) Diabetic Retinopathy (DR) Artificial Intelligence Screening System Product Offered
11.10.3 EyRIS (SELENA+) Diabetic Retinopathy (DR) Artificial Intelligence Screening System Revenue, Gross Margin and Market Share (2019-2024)
11.10.4 EyRIS (SELENA+) Main Business Overview
11.10.5 EyRIS (SELENA+) Latest Developments
11.11 Vistel
11.11.1 Vistel Company Information
11.11.2 Vistel Diabetic Retinopathy (DR) Artificial Intelligence Screening System Product Offered
11.11.3 Vistel Diabetic Retinopathy (DR) Artificial Intelligence Screening System Revenue, Gross Margin and Market Share (2019-2024)
11.11.4 Vistel Main Business Overview
11.11.5 Vistel Latest Developments
11.12 RETINA-AI Health
11.12.1 RETINA-AI Health Company Information
11.12.2 RETINA-AI Health Diabetic Retinopathy (DR) Artificial Intelligence Screening System Product Offered
11.12.3 RETINA-AI Health Diabetic Retinopathy (DR) Artificial Intelligence Screening System Revenue, Gross Margin and Market Share (2019-2024)
11.12.4 RETINA-AI Health Main Business Overview
11.12.5 RETINA-AI Health Latest Developments
11.13 Acer Medical
11.13.1 Acer Medical Company Information
11.13.2 Acer Medical Diabetic Retinopathy (DR) Artificial Intelligence Screening System Product Offered
11.13.3 Acer Medical Diabetic Retinopathy (DR) Artificial Intelligence Screening System Revenue, Gross Margin and Market Share (2019-2024)
11.13.4 Acer Medical Main Business Overview
11.13.5 Acer Medical Latest Developments
12 Research Findings and Conclusion

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂